# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-24-014660
Filing Date
2024-04-03
Accepted
2024-04-03 17:17:21
Documents
40
Period of Report
2024-06-04

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | sgmo-20240403.htm iXBRL | PRE 14A | 1801204
6 | GRAPHIC | sgmo-20240403_g1.jpg | GRAPHIC | 672244
7 | GRAPHIC | sgmo-20240403_g10.jpg | GRAPHIC | 110929
8 | GRAPHIC | sgmo-20240403_g11.jpg | GRAPHIC | 169809
9 | GRAPHIC | sgmo-20240403_g12.jpg | GRAPHIC | 126701
10 | GRAPHIC | sgmo-20240403_g13.jpg | GRAPHIC | 107642
11 | GRAPHIC | sgmo-20240403_g14.jpg | GRAPHIC | 133429
12 | GRAPHIC | sgmo-20240403_g15.jpg | GRAPHIC | 95551
13 | GRAPHIC | sgmo-20240403_g16.jpg | GRAPHIC | 174100
14 | GRAPHIC | sgmo-20240403_g17.jpg | GRAPHIC | 94755
15 | GRAPHIC | sgmo-20240403_g18.jpg | GRAPHIC | 703536
16 | GRAPHIC | sgmo-20240403_g19.jpg | GRAPHIC | 137119
17 | GRAPHIC | sgmo-20240403_g2.jpg | GRAPHIC | 249916
18 | GRAPHIC | sgmo-20240403_g20.gif | GRAPHIC | 17512
19 | GRAPHIC | sgmo-20240403_g21.jpg | GRAPHIC | 34423
20 | GRAPHIC | sgmo-20240403_g22.jpg | GRAPHIC | 168613
21 | GRAPHIC | sgmo-20240403_g23.jpg | GRAPHIC | 123359
22 | GRAPHIC | sgmo-20240403_g24.jpg | GRAPHIC | 288976
23 | GRAPHIC | sgmo-20240403_g25.jpg | GRAPHIC | 284046
24 | GRAPHIC | sgmo-20240403_g3.jpg | GRAPHIC | 686574
25 | GRAPHIC | sgmo-20240403_g4.jpg | GRAPHIC | 942320
26 | GRAPHIC | sgmo-20240403_g5.jpg | GRAPHIC | 712281
27 | GRAPHIC | sgmo-20240403_g6.gif | GRAPHIC | 17563
28 | GRAPHIC | sgmo-20240403_g7.jpg | GRAPHIC | 105454
29 | GRAPHIC | sgmo-20240403_g8.jpg | GRAPHIC | 141378
30 | GRAPHIC | sgmo-20240403_g9.jpg | GRAPHIC | 122997
| Complete submission text file | 0001628280-24-014660.txt |  | 17459674

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sgmo-20240403.xsd | EX-101.SCH | 5579
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sgmo-20240403_def.xml | EX-101.DEF | 4209
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sgmo-20240403_lab.xml | EX-101.LAB | 11732
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sgmo-20240403_pre.xml | EX-101.PRE | 7396
43 | EXTRACTED XBRL INSTANCE DOCUMENT | sgmo-20240403_htm.xml | XML | 99068

Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-30171 | Film No.: 24820080
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)